The US food and Drug Administration has published a major final guidance that seeks to further expand its abbreviated 510(k) program. Alongside the guidance, regulators have also proposed corresponding draft guidances that would guide the types of medical devices that could be reviewed under the expanded program.
The agency released the guidances on 19 September, only a week after it published four updated guidance docs aimed at clarifying the agency's thinking on its Special and Abbreviated 510(k) Programs, and explaining how to format traditional and abbreviated 510(k) submissions, as well as when the FDA would issue refuse-to-accept letters for 510(k) submissions